The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
As companies face mounting pressure from both regulators and the public to address PFAS risks, Battelle has developed a comprehensive framework to help businesses confidently understand, quantify and manage PFAS risk.
In this Q&A, we explore the evolution of AI in medical device development, Battelle's pioneering role in this journey, and how to responsibly advance innovation in the "AI Age."
2024 was yet another impressive year for NEON in terms of both the breadth and scale of research that it has enabled. As we turn the calendar to 2025, here’s a look back at some of the most exciting research and news involving the NEON program last year.
The persistence of PFAS in the environment and potential health risks have led to regulatory actions affecting the medical device industry. In this blog, learn key PFAS details and how to address PFAS challenges for medical device companies.
Managing PFAS risk is no longer optional—it’s essential. In this blog, learn the 5 main categories of PFAS risk and key management tactics used to address them.
Battelle played a pivotal role in showcasing our leadership in scientific research and innovation at this year's American Geophysical Union (AGU) Annual Meeting.
Follow along with the latest news, announcement and updates from our Battelle community of solvers.
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. By continuing to browse our
site without changing your settings, you are agreeing to accept all cookies on the site.
